{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:03:00Z","timestamp":1790060580670,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"crossref","award":["MRG5980222"],"award-info":[{"award-number":["MRG5980222"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"crossref","award":["RTA6080003"],"award-info":[{"award-number":["RTA6080003"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004192","name":"National Science and Technology Development Agency Thailand","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004192","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chiang Mai University Center of Excellence Award"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejphar.2018.01.015","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T21:43:39Z","timestamp":1517348619000},"page":"43-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Combined iron chelator and T-type calcium channel blocker exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice"],"prefix":"10.1016","volume":"822","author":[{"given":"Sirinart","family":"Kumfu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juthamas","family":"Khamseekaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siripong","family":"Palee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somdet","family":"Srichairatanakool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suthat","family":"Fucharoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siriporn C.","family":"Chattipakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipon","family":"Chattipakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.01.015_bib1","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1182\/blood.V97.11.3411","article-title":"Cardiac involvement in thalassemia intermedia: a multicenter study","volume":"97","author":"Aessopos","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2018.01.015_bib2","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3324\/haematol.10915","article-title":"Heart disease in thalassemia intermedia: a review of the underlying pathophysiology","volume":"92","author":"Aessopos","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.ejphar.2018.01.015_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/109980040000200106","article-title":"Iron-overload cardiomyopathy: evidence for a free radical--mediated mechanism of injury and dysfunction in a murine model","volume":"2","author":"Bartfay","year":"2000","journal-title":"Biol. Res. Nurs."},{"key":"10.1016\/j.ejphar.2018.01.015_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/JBM.S27400","article-title":"Treating thalassemia major-related iron overload: the role of deferiprone","volume":"3","author":"Berdoukas","year":"2012","journal-title":"J. Blood. Med."},{"key":"10.1016\/j.ejphar.2018.01.015_bib5","doi-asserted-by":"crossref","first-page":"e112915","DOI":"10.1371\/journal.pone.0112915","article-title":"Iron overload and apoptosis of HL-1 cardiomyocytes: effects of calcium channel blockade","volume":"9","author":"Chen","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2018.01.015_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/109980040200300404","article-title":"Amlodipine decreases iron uptake and oxygen free radical production in the heart of chronically iron overloaded mice","volume":"3","author":"Crowe","year":"2002","journal-title":"Biol. Res. Nurs."},{"key":"10.1016\/j.ejphar.2018.01.015_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/ejh.12977","article-title":"A randomized, controlled study evaluating effects of amlodipine addition to chelators to reduce iron loading in patients with thalassemia major","volume":"99","author":"Eghbali","year":"2017","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ejphar.2018.01.015_bib8","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1182\/blood-2016-06-721183","article-title":"A randomized trial of amlodipine in addition to standard chelation therapy in patients with thalassemia major","volume":"128","author":"Fernandes","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2018.01.015_bib9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.amjmed.2013.05.002","article-title":"Amlodipine reduces cardiac iron overload in patients with thalassemia major: a pilot trial","volume":"126","author":"Fernandes","year":"2013","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2018.01.015_bib10","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1182\/blood-2005-02-0460","article-title":"Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells","volume":"106","author":"Glickstein","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2018.01.015_bib11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jpba.2006.07.030","article-title":"Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography-visible detection","volume":"43","author":"Grotto","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejphar.2018.01.015_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijcard.2006.08.076","article-title":"Heart rate variability in beta-thalassemic mice","volume":"121","author":"Incharoen","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2018.01.015_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2017.02.015","article-title":"Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice","author":"Khamseekaew","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.015_bib14","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.111.050773","article-title":"Iron overload cardiomyopathy in clinical practice","volume":"124","author":"Kremastinos","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2018.01.015_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCHEARTFAILURE.109.913863","article-title":"Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives","volume":"3","author":"Kremastinos","year":"2010","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ejphar.2018.01.015_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-0609.2012.01779.x","article-title":"T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice","volume":"88","author":"Kumfu","year":"2012","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ejphar.2018.01.015_bib17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1600-0609.2010.01549.x","article-title":"T-type calcium channel as a portal of iron uptake into cardiomyocytes of beta-thalassemic mice","volume":"86","author":"Kumfu","year":"2011","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ejphar.2018.01.015_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1113\/EP085517","article-title":"Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice","volume":"101","author":"Kumfu","year":"2016","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ejphar.2018.01.015_bib19","doi-asserted-by":"crossref","first-page":"H1004","DOI":"10.1152\/ajpheart.00156.2011","article-title":"Creation of myocardial fibrosis by transplantation of fibroblasts primed with survival factors","volume":"301","author":"Lee","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2018.01.015_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0828-282X(09)70064-9","article-title":"Iron overload thalassemic cardiomyopathy: iron status assessment and mechanisms of mechanical and electrical disturbance due to iron toxicity","volume":"25","author":"Lekawanvijit","year":"2009","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ejphar.2018.01.015_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00395-004-0476-5","article-title":"Left ventricular pressure-volume measurements in mice: comparison of closed-chest versus open-chest approach","volume":"99","author":"Lips","year":"2004","journal-title":"Basic. Res. Cardiol."},{"key":"10.1016\/j.ejphar.2018.01.015_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1053\/beha.2002.0209","article-title":"Oral iron chelators--development and application","volume":"15","author":"Liu","year":"2002","journal-title":"Best. Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.ejphar.2018.01.015_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/BJ20140795","article-title":"A novel method for non-transferrin-bound iron quantification by chelatable fluorescent beads based on flow cytometry","volume":"463","author":"Ma","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2018.01.015_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1254\/fpj.105.437","article-title":"[Effect of efonidipine hydrochloride, a calcium channel blocker, on the experimental cerebral ischemia\/anoxia]","volume":"105","author":"Matsumura","year":"1995","journal-title":"Nihon. Yakurigaku. Zasshi."},{"key":"10.1016\/j.ejphar.2018.01.015_bib25","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cardfail.2010.05.009","article-title":"Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment","volume":"16","author":"Murphy","year":"2010","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ejphar.2018.01.015_bib26","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm920","article-title":"L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy","volume":"9","author":"Oudit","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2018.01.015_bib27","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1161\/01.CIR.0000124229.40424.80","article-title":"Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model","volume":"109","author":"Oudit","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2018.01.015_bib28","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/nprot.2008.138","article-title":"Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats","volume":"3","author":"Pacher","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2018.01.015_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3324\/haematol.2009.019042","article-title":"Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging","volume":"96","author":"Pepe","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.ejphar.2018.01.015_bib30","first-page":"411","article-title":"An update on iron chelation therapy","volume":"10","author":"Poggiali","year":"2012","journal-title":"Blood. Transfus."},{"key":"10.1016\/j.ejphar.2018.01.015_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jbbm.2003.11.003","article-title":"Microanalysis of non-heme iron in animal tissues","volume":"58","author":"Rebouche","year":"2004","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.ejphar.2018.01.015_bib32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1600-0609.2009.01314.x","article-title":"Heart rate variability in beta-thalassemia patients","volume":"83","author":"Rutjanaprom","year":"2009","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ejphar.2018.01.015_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1527-3466.2002.tb00084.x","article-title":"Efonidipine hydrochloride: a dual blocker of l- and T-type ca(2+) channels","volume":"20","author":"Tanaka","year":"2002","journal-title":"Cardiovasc. Drug. Rev."},{"key":"10.1016\/j.ejphar.2018.01.015_bib34","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.106.648790","article-title":"A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance","volume":"115","author":"Tanner","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2018.01.015_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/exmp.1999.2278","article-title":"Characterization of hepatic iron overload following dietary administration of dicyclopentadienyl iron (Ferrocene) to mice: cellular, biochemical, and molecular aspects","volume":"68","author":"Valerio","year":"2000","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ejphar.2018.01.015_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1124\/jpet.110.172668","article-title":"Iron-induced cardiac damage: role of apoptosis and deferasirox intervention","volume":"336","author":"Wang","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.01.015_bib37","first-page":"704","article-title":"Inherited haemoglobin disorders: an increasing global health problem","volume":"79","author":"Weatherall","year":"2001","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ejphar.2018.01.015_bib38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2015.08.017","article-title":"Current and future treatment strategies for iron overload cardiomyopathy","volume":"765","author":"Wongjaikam","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.015_bib39","doi-asserted-by":"crossref","first-page":"44460","DOI":"10.1038\/srep44460","article-title":"Restoring the impaired cardiac calcium homeostasis and cardiac function in iron overload rats by the combined deferiprone and N-acetyl cysteine","volume":"7","author":"Wongjaikam","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2018.01.015_bib40","doi-asserted-by":"crossref","first-page":"e0159414","DOI":"10.1371\/journal.pone.0159414","article-title":"Combined iron chelator and antioxidant exerted greater efficacy on cardioprotection than monotherapy in iron-overloaded rats","volume":"11","author":"Wongjaikam","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2018.01.015_bib41","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1073\/pnas.92.25.11608","article-title":"A mouse model for beta 0-thalassemia","volume":"92","author":"Yang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918300165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918300165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T12:25:19Z","timestamp":1535113519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918300165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":41,"alternative-id":["S0014299918300165"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.015","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined iron chelator and T-type calcium channel blocker exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}